Ginkgo Bioworks Holdings annual operating cash flow
2019
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Operating Cash Flow Growth & History (DNA)
Ginkgo Bioworks Holdings's operating cash flow was −$171.1M for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$171.1M | $148.5M | — |
| 2024 | 2024-12-31 | −$319.6M | −$24.1M | — |
| 2023 | 2023-12-31 | −$295.5M | −$43.3M | — |
| 2022 | 2022-12-31 | −$252.2M | $1.6M | — |
| 2021 | 2021-12-31 | −$253.8M | −$118.0M | — |
| 2020 | 2020-12-31 | −$135.8M | −$91.2M | — |
| 2019 | 2019-12-31 | −$44.7M | — | — |
Ginkgo Bioworks Holdings quarterly operating cash flow
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$44.3M | −$4.0M | — |
| Q1 2026 | 2026-03-31 | −$46.7M | $4.8M | — |
| Q4 2025 | 2025-12-31 | −$47.7M | −$5.2M | — |
| Q3 2025 | 2025-09-30 | −$31.6M | $71.9M | — |
| Q2 2025 | 2025-06-30 | −$40.3M | $44.1M | — |
| Q1 2025 | 2025-03-31 | −$51.5M | $37.7M | — |
| Q4 2024 | 2024-12-31 | −$42.4M | $15.4M | — |
| Q3 2024 | 2024-09-30 | −$103.5M | −$29.9M | — |
| Q2 2024 | 2024-06-30 | −$84.4M | −$10.9M | — |
| Q1 2024 | 2024-03-31 | −$89.3M | $1.3M | — |
| Q4 2023 | 2023-12-31 | −$57.8M | $46.7M | — |
| Q3 2023 | 2023-09-30 | −$73.6M | −$45.2M | — |
| Q2 2023 | 2023-06-30 | −$73.5M | $25.9M | — |
| Q1 2023 | 2023-03-31 | −$90.6M | −$70.7M | — |
| Q4 2022 | 2022-12-31 | −$104.5M | $61.0M | — |
| Q3 2022 | 2022-09-30 | −$28.4M | −$23.1M | — |
| Q2 2022 | 2022-06-30 | −$99.4M | −$64.5M | — |
| Q1 2022 | 2022-03-31 | −$19.9M | $28.2M | — |
| Q4 2021 | 2021-12-31 | −$165.5M | — | — |
| Q3 2021 | 2021-09-30 | −$5.2M | — | — |
| Q2 2021 | 2021-06-30 | −$34.9M | — | — |
| Q1 2021 | 2021-03-31 | −$48.1M | — | — |
Ginkgo Bioworks Holdings operating cash flow trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's operating cash flow decreased from −$135.8M to −$171.1M, a change of −$35.2M. The latest reported quarter, Q2 2026, shows −$44.3M.
About the metric
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
Calculation and source
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...